POZEN Inc., headquartered in Chapel Hill, NC, is a progressive pharmaceutical company committed to transforming medicine that transforms lives. POZEN’s unique in-source business model has been proven through our success in gaining U.S. FDA approval of two self-invented products in two years – something almost no other small pharmaceutical company has achieved. Moving forward, POZEN continues to be dedicated to addressing unmet needs and developing affordable medicines for patients and physicians.
Since our founding in 1996, POZEN has had a long, successful history of creating novel pharmacologic agents by combining existing drug therapies that result in superior patient outcomes. This approach allows for a potentially higher success rate than NCE (new chemical entity) development.
Stock Symbol: POZN
06/18/13 4:00 p.m. ET
NASDAQ: Pozen $5.12
Change: + 0.09 (1.79%)